Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Thoratec Corp (NASDAQ:THOR)

62.66
Delayed Data
As of Sep 03
 -0.13 / -0.21%
Today’s Change
24.86
Today|||52-Week Range
63.51
+93.04%
Year-to-Date

Today’s Trading

Previous close62.79
Today’s open62.79
Day’s range62.56 - 62.86
Volume544,852
Average volume (3 months)1,292,460
Market cap$3.4B
Dividend yield--
Data as of 09/03/2015

Growth & Valuation

Earnings growth (last year)-29.37%
Earnings growth (this year)-1.61%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-5.02%
P/E ratio89.7
Price/Sales3.87
Price/Book5.37

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...-2.08-4.40%
PCRXPacira Pharmaceutica...-0.37-0.65%
CMNCantel Medical Corp-0.37-0.75%
CYBXCyberonics Inc+0.49+0.76%
Data as of 09/03/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)$0.28
Annual revenue (last year)$477.6M
Annual profit (last year)$50.4M
Net profit margin10.55%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
D. Keith Grossman
Chief Financial Officer &
Vice President
Taylor C. Harris
Corporate headquarters
Pleasanton, California

Forecasts

Partner Offers